Devivasha Bordoloi

4.7k total citations · 1 hit paper
50 papers, 3.7k citations indexed

About

Devivasha Bordoloi is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Devivasha Bordoloi has authored 50 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Immunology and 11 papers in Oncology. Recurrent topics in Devivasha Bordoloi's work include Curcumin's Biomedical Applications (8 papers), Immunotherapy and Immune Responses (7 papers) and Cell death mechanisms and regulation (6 papers). Devivasha Bordoloi is often cited by papers focused on Curcumin's Biomedical Applications (8 papers), Immunotherapy and Immune Responses (7 papers) and Cell death mechanisms and regulation (6 papers). Devivasha Bordoloi collaborates with scholars based in India, United States and Singapore. Devivasha Bordoloi's co-authors include Ajaikumar B. Kunnumakkara, Ganesan Padmavathi, Nand Kishor Roy, Javadi Monisha, Kishore Banik, Bharat B. Aggarwal, Gautam Sethi, Choudhary Harsha, Sahdeo Prasad and Bethsebie Lalduhsaki Sailo and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and Science Advances.

In The Last Decade

Devivasha Bordoloi

50 papers receiving 3.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases

2016 795 citations Ajaikumar B. Kunnumakkara, Devivasha Bordoloi et al. British Journal of Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Devivasha Bordoloi India	30	1.9k	859	621	431	425	50	3.7k
Kishore Banik India	35	2.0k 1.0×	488 0.6×	646 1.0×	519 1.2×	413 1.0×	46	3.7k
Ganesan Padmavathi India	27	1.5k 0.8×	613 0.7×	495 0.8×	377 0.9×	262 0.6×	43	2.9k
Vivek R. Yadav United States	28	1.7k 0.9×	446 0.5×	413 0.7×	340 0.8×	381 0.9×	60	3.5k
Ruby John Anto India	34	1.9k 1.0×	991 1.2×	346 0.6×	293 0.7×	383 0.9×	80	3.8k
Guang Liang China	40	2.3k 1.2×	664 0.8×	420 0.7×	301 0.7×	428 1.0×	129	4.7k
Pornngarm Limtrakul Thailand	35	2.3k 1.2×	1.5k 1.8×	562 0.9×	565 1.3×	1.0k 2.4×	120	4.7k
Seong‐Su Han United States	25	2.0k 1.0×	446 0.5×	441 0.7×	497 1.2×	409 1.0×	41	3.7k
Chi‐Cheng Lu Taiwan	42	2.7k 1.4×	418 0.5×	639 1.0×	420 1.0×	575 1.4×	140	5.0k
Vladimir Badmaev United States	35	2.3k 1.2×	1.8k 2.1×	1.2k 1.9×	616 1.4×	366 0.9×	73	5.3k
Santosh K. Sandur India	34	3.1k 1.6×	1.4k 1.6×	638 1.0×	388 0.9×	858 2.0×	88	5.9k

Countries citing papers authored by Devivasha Bordoloi

Since Specialization

Citations

This map shows the geographic impact of Devivasha Bordoloi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devivasha Bordoloi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devivasha Bordoloi more than expected).

Fields of papers citing papers by Devivasha Bordoloi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devivasha Bordoloi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devivasha Bordoloi. The network helps show where Devivasha Bordoloi may publish in the future.

Co-authorship network of co-authors of Devivasha Bordoloi

This figure shows the co-authorship network connecting the top 25 collaborators of Devivasha Bordoloi. A scholar is included among the top collaborators of Devivasha Bordoloi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devivasha Bordoloi. Devivasha Bordoloi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

O’Connell, Ryan P., Kevin Liaw, Nils Wellhausen, et al.. (2024). Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 12(6). e008733–e008733. 6 indexed citations

Bordoloi, Devivasha, et al.. (2024). Abstract PR-006: A novel bispecific NK cell engager targeting FSHR and Siglec-7 displays potent anti-tumor immunity against ovarian cancer. Cancer Research. 84(5_Supplement_2). PR–6. 1 indexed citations

Park, Daniel H., Pratik Bhojnagarwala, Kevin Liaw, et al.. (2024). Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune cells. Journal for ImmunoTherapy of Cancer. 12(12). e009604–e009604. 4 indexed citations

Park, Daniel H., Kevin Liaw, Pratik Bhojnagarwala, et al.. (2023). Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escape. Molecular Therapy — Oncolytics. 28. 249–263. 11 indexed citations

Adeniji, Opeyemi S., Devivasha Bordoloi, Jeff Martinson, et al.. (2023). Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2. mBio. 14(1). e0339322–e0339322. 9 indexed citations

Bordoloi, Devivasha, Pratik Bhojnagarwala, Alfredo Perales‐Puchalt, et al.. (2022). A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy. JCI Insight. 7(22). 14 indexed citations

Zhu, Xizhou, Alfredo Perales‐Puchalt, Ziyang Xu, et al.. (2021). DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas. Molecular Therapy — Oncolytics. 24. 218–229. 5 indexed citations

Mahalingam, Sundarasamy, Ziyang Xu, Devivasha Bordoloi, et al.. (2021). Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing. Heliyon. 7(4). e06836–e06836. 15 indexed citations

Bordoloi, Devivasha, Ganesan Padmavathi, Kishore Banik, et al.. (2021). Human tumor necrosis factor alpha-induced protein eight-like 1 exhibited potent anti-tumor effect through modulation of proliferation, survival, migration and invasion of lung cancer cells. Molecular and Cellular Biochemistry. 476(9). 3303–3318. 9 indexed citations

10.

Bordoloi, Devivasha, Kishore Banik, Krishan Kumar Thakur, et al.. (2020). Inflection of Akt/mTOR/STAT-3 cascade in TNF-α induced protein 8 mediated human lung carcinogenesis. Life Sciences. 262. 118475–118475. 16 indexed citations

11.

Khwairakpam, Amrita Devi, Javadi Monisha, Nand Kishor Roy, et al.. (2019). Vietnamese coriander inhibits cell proliferation, survival and migration via suppression of Akt/mTOR pathway in oral squamous cell carcinoma. Journal of Basic and Clinical Physiology and Pharmacology. 31(3). 36 indexed citations

12.

Roy, Nand Kishor, Parama Dey, Kishore Banik, et al.. (2019). An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases. International Journal of Molecular Sciences. 20(17). 4101–4101. 169 indexed citations

13.

Kunnumakkara, Ajaikumar B., Kishore Banik, Devivasha Bordoloi, et al.. (2018). Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases. Frontiers in Pharmacology. 9. 686–686. 96 indexed citations

14.

Harsha, Choudhary, Kishore Banik, Devivasha Bordoloi, & Ajaikumar B. Kunnumakkara. (2017). Antiulcer properties of fruits and vegetables: A mechanism based perspective. Food and Chemical Toxicology. 108(Pt A). 104–119. 66 indexed citations

15.

Banik, Kishore, Choudhary Harsha, Devivasha Bordoloi, et al.. (2017). Therapeutic potential of gambogic acid, a caged xanthone, to target cancer. Cancer Letters. 416. 75–86. 135 indexed citations

16.

Thakur, Krishan Kumar, Devivasha Bordoloi, & Ajaikumar B. Kunnumakkara. (2017). Alarming Burden of Triple-Negative Breast Cancer in India. Clinical Breast Cancer. 18(3). e393–e399. 112 indexed citations

17.

Kunnumakkara, Ajaikumar B., Devivasha Bordoloi, Ganesan Padmavathi, et al.. (2016). Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. British Journal of Pharmacology. 174(11). 1325–1348. 795 indexed citations breakdown →

18.

Monisha, Javadi, et al.. (2016). NF-?B Blockers Gifted by Mother Nature: Prospectives in Cancer Cell Chemosensitization. Current Pharmaceutical Design. 22(27). 4173–4200. 55 indexed citations

19.

Monisha, Javadi, Nand Kishor Roy, Devivasha Bordoloi, et al.. (2016). Nuclear Factor Kappa B: A Potential Target to Persecute Head and Neck Cancer. Current Drug Targets. 18(2). 232–253. 41 indexed citations

20.

Bordoloi, Devivasha, et al.. (2015). Diverse expression of sucrose transporter gene family in Zea mays. Journal of Genetics. 94(1). 151–154. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact